Regulation of muscle creatine kinase by phosphorylation in normal and diabetic hearts

Protein kinase C (PKC) is an important signaling molecule in the heart, but its targets remain unclear. Using a PKC substrate antibody, we detected a 40-kDa phosphorylated cardiac protein that was subsequently identified by tandem mass spectroscopy as muscle creatine kinase (M-CK) with phosphorylation at serine 128. The forward reaction using ATP to generate phosphocreatine was reduced, while the reverse reaction using phosphocreatine to generate ATP was increased following dephosphorylation of immunoprecipitated M-CK with protein phosphatase 2A (PP2A) or PP2C. Despite higher PKC levels in diabetic hearts, decreased phosphorylation of M-CK was more prominent than the reduction in its expression. Changes in CK activity in diabetic hearts were similar to those found following dephosphorylation of M-CK from control hearts. The decrease in phosphorylation may act as a compensatory mechanism to maintain CK activity at an appropriate level for cytosolic ATP regeneration in the diabetic heart. Received 15 September 2008; received after revision 30 September 2008; accepted 13 October 2008     

不同运动负荷后对高原短跑运动员血清肌酸激酶的影响

对云南省短跑男子运动员10人（国家一级2人，二级8人）以不同的负荷训练后，测试运动员血清肌酸激酶的变化情况，实验结果表明，运动员在训练前后，由于负荷强度不同和运动员的训练水平不同，可以引起血清肌酸激酶的不同变化。它可以作为评定做功肌肉所承受的训练负荷，及了解骨骼肌微细损伤和肌肉对所施加负荷的适应与恢复情况的重要生化指标，为高原短跑训练提供科学训练的依据。     

重组酵母Saccharom yces cerevisiae蛋白激酶Sch9的分泌表达与活性鉴定

为了深入研究蛋白激酶Sch9的生物化学特性,在Pichia pastoris酵母KM71H菌种中分泌表达并纯化了重组Sch9蛋白.进一步通过体外磷酸化实验分析了重组Sch9蛋白的蛋白激酶活性.通过重组蛋白质工程的手段初步研究了Sch9蛋白的生物化学和酶学特性.     

补虚化瘀法对产后抑郁低雌激素大鼠海马RSK1和MEK1的影响

目的：探讨补虚化瘀方药参归仁合剂对产后抑郁大鼠海马神经元内胞外信号调节激酶1/2(ERK1/2)通路的影响,测定P90核糖体S6激酶（RSK1）和丝裂原活化细胞外调节激酶1(MEK1)蛋白表达量。方法：56只雌性大鼠分为正常组,模型组,参归仁高、中、低剂量组（7,3.6,1.8 g·kg-1·d-1）,盐酸舍曲林组（4.5 mg·kg-1·d-1）、苯甲酸雌二醇组（10 μg·d-1）,除正常组外,其余各组均采用苯甲酸雌二醇和黄体酮造模,模拟产后抑郁状态。使用蛋白质免疫印迹(Western blot)法检测其海马P-RSK1和P-MEK1的蛋白表达量。结果：与模型组比较,参归仁中剂量组和舍曲林组在海马组织中P-RSK1蛋白表达水平明显增加（P＜0.01）;与模型组比较,参归仁中剂量组、舍曲林组和苯甲酸雌二醇组在海马组织中P-MEK1蛋白表达水平明显增加（P＜0.01）。结论：参归仁合剂可增加海马组织中P-RSK1和P-MEK1蛋白表达量,且参归仁中剂量组效果显著,参归仁合剂可起到抗抑郁作用。     

The neural mechanisms of pain-related affect and memory

The pain experience includes a sensory-discriminative and an emotional-affective components. The affective dimension refers to the unpleasantness or aversion of sensation. The great progress at the genetic, molecular, cellular, and systemic levels on the study of the sensory dimension of pain has been made over past four decades. However, “to consider only the sensory features of pain, and ignore its motivational and affective properties, is to look at only part of the problem and not even the most important part of that”. A line of clinic observations indicate that the patients with chronic pain suffer from much more affective disturbance than pain itself. Obviously, physiological arousal and hypervigilance to pain cause negative affect, such as anxiety, anger, worry, aversion, even tendency of suicide, these negative affective states in turn enhance pain sensation. Today, more and more attention has been paid to the study on mechanisms underlying affective dimension of pain. In order to deepen and expand our understanding of the nature of pain, this review summarizes the main progress and recent findings from our laboratory regarding affective component of pain in neuroanatomy, neurophysiology, and cell biochemistry.     

植物细胞钙靶蛋白的研究进展

简述了植物细胞的钙离子调控过程，对钙调蛋白、钙调磷酸酶B类蛋白和钙离子依赖型蛋白质激酶3类钙靶蛋白的最新研究进展进行了综述。     

MAP kinase specifically mediates the ABA-induced H<Subscript>2</Subscript>O<Subscript>2</Subscript> generation in guard cells of<Emphasis Type="Italic">Vicia faba</Emphasis> L.

The plant hormone abscisic acid (ABA) is involved in regulating adverse physiological processes, including stomatal closure, seed development and germination, and mediating many environmental stress responses, such as drought, salinity and extreme temperatures[1,2]. In re-sponse to various stress stimuli, ABA synthesis is in-creased in plant cells, which triggers a series of physio-logical responses to adapt the stress conditions[1—3]. For example, under water deficit, ABA acts directly on…     

Characterization of a calmodulin binding protein kinase from<Emphasis Type="Italic">Arabidopsis thalian</Emphasis>

A full-length calmodulin binding protein kinase cDNA ,AtCBK1 ,from Arabidopsis has been isolated by screening of an Arabidopsis cDNA library and by 5′-RACE-Northern blot and in situ hybridization indicated that the expression of AtCBK1 was more abundant in the vascular bundles and the meristems than in other tissues,The phylogenetic analyses revenl that AtCBK1 is different from animal CaMKs and it falls into CRK subgroup,indicating that they may come from different ancestors,The result suggests that AtCBK1 encoldes a CaM-binding serine/threonine protein kinase.     

Modulating multidrug resistance through inhibiting of protein kinase C activity by phenothiazines

In the present study, actions of phenothiazines(PTZ) in reversing multidrug resistance(MDR) and inhibiting PKC activity were investigated. It was found that the three PTZs caused 2.49, 36.58 and 75.78 fold reversal of K562/AO2 MDR cells resistant to adriamycin, respectively, while the chemosensitizer verapamil caused 40 fold reversal in the same condition, indicating that PTZ11 is a novel reversal agent of MDR and a potential chemotherapeutic reagent for tumor therapy. PKC activity analysis in the presence of PTZs showd that PTZ6 and PTZ11 inhibited rat brain protein kinase C activity in a manner of dose_dependent. The IC 50 values were (489.77±31.4) and (113±9.64) μmol/L, respectively. PTZ7 had no inhibition on PKC activity. Further study showed that PTZ11 could reduce PMA_mediated activation of PKC in a manner of dose_dependent, suggesting that PTZ11 might compete for the high_affinity phorbol ester binding site within PKC molecule. Recently, an X_ray structure of PMA in complex with PKC Cys2 activator_binding domain was solved. We therefore decided to explore the possible binding model of PTZ11 with PKC molecule using SYBYL 6.02 program. It was shown that the binding site of PTZ11 with PKC molecule partially overlapped with that of PMA, providing for the first time new data for designing PKC inhibitors and MDR reversal drugs.